RI-STAD 2 TP2129
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AKAP disruptor. Selectively binds PKA-RI with high affinity (KD values are 6.2 and 12.1 nM for the RI_ and _ subunits, respectively) and blocks its interaction with AKAP. Inhibits type I PKA-mediated phosphorylation in live cells. Cell permeable.
CAS nr:
TP2129
Purity:
98%
Molecular Weight:
2401,75
SMILES:
Formula:
C109H181N25O35
Pathway:
Target:
